Bin Pang

Bin Pang

Auto-generated profile, based on publicly available information

Bin Pang

Shanghai Key Laboratory of Metabolic Remodeling and Health, Institute of Metabolism and Integrative Biology, Fudan University, Shanghai 200437, China

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 February 2024 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
RTRujuan Ti
Rujuan Ti
BPBin Pang
Bin Pang
LYLeiye Yu
Leiye Yu
BGBing Gan
Bing Gan
WMWenzhuo Ma
Wenzhuo Ma
Lizhe ZhuLizhe Zhu
Lizhe Zhu
Physics-based simulation methods can grant atomistic insights into the molecular origin of the function of biomolecules. However, the potential of such approaches has been hindered by their low efficiency, including in the design of selective agonists where simulations of myriad protein–ligand combinations are necessary. Here, we describe an automated input-free path searching protocol that offers (within 14 d using Graphics Processing Unit servers) a minimum free energy path (MFEP) defined in high-dimension configurational space for activating sphingosine-1-phosphate receptors (S1PRs) by arbitrary ligands. The free energy distributions along the MFEP for four distinct ligands and three S1PRs reached a remarkable agreement with Bioluminescence Resonance Energy Transfer (BRET) measurements of G-protein dissociation. In particular, the revealed transition state structures pointed out toward two S1PR3 residues F263/I284, that dictate the preference of existing agonists CBP307 and BAF312 on S1PR1/5. Swapping these residues between S1PR1 and S1PR3 reversed their response to the two agonists in BRET assays. These results inspired us to design improved agonists with both strong polar head and bulky hydrophobic tail for higher selectivity on S1PR1. Through merely three in silico iterations, our tool predicted a unique compound scaffold. BRET assays confirmed that both chiral forms activate S1PR1 at nanomolar concentration, 1 to 2 orders of magnitude less than those for S1PR3/5. Collectively, these results signify the promise of our approach in fine agonist design for G-protein-coupled receptors.

16 May 2023 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Open access
XWXiaomei Wu
Xiaomei Wu
BPBin Pang
Bin Pang
JYJianwei You
Jianwei You
LYLeiye Yu
Leiye Yu
RRRuobing Ren
Ruobing Ren
LCLi Chen
Li Chen
Sphingosine-1-phosphate (S1P) is an active signaling metabolite synthesized by blood cells, exported into blood stream, and can trigger many downstream signaling pathways with disease implications. Understanding how S1P is transported is of great values for dissecting the function of S1P, but most existing methods for measuring S1P transporter activity use radioactive substrates or involve multiple workup steps, hindering their broader uses. In this study, we develop a workflow combining sensitive LC-MS measurement and a cell-based transporter protein system to measure the export activity of S1P transporter proteins. Our workflow demonstrated good applications in studying different S1P transporters SPNS2 and MFSD2B, WT and mutated protein, and different protein substrates. In summary, we provide a simple yet versatile workflow for measuring the export activity of S1P transporters, facilitating future studies of S1P transport mechanism and drug development.

8 October 2026 in hLife
Verified
Journal Article
Open access
BPBin Pang
Bin Pang
LYLeiye Yu
Leiye Yu
BGBing Gan
Bing Gan
ZQZhaoyang Qin
Zhaoyang Qin
WWWeidi Wang
Weidi Wang
RRRuobing Ren
Ruobing Ren